Mount Sinai - St. Luke's — New York, New York

Mount Sinai - St. Luke's is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai - St. Luke's has participated in 1 clinical trials.

Therapeutic areas: Common Warts, HPV (Human Papillomavirus), Periungual Warts.

Sponsors: RXi Pharmaceuticals, Corp..

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai - St. Luke's?

Mount Sinai - St. Luke's has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai - St. Luke's conducted?

Mount Sinai - St. Luke's has 1 clinical trials on record. Their work covers Common Warts, HPV (Human Papillomavirus), Periungual Warts.

Is Mount Sinai - St. Luke's accredited by Crixeo Health?

Mount Sinai - St. Luke's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai - St. Luke's?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.